子宮内膜症治療の市場規模、シェア、動向分析レポート：治療タイプ別、薬物クラス（NSAIDs）別、投与経路別、流通チャネル別、地域別、セグメント別予測、2023年～2030年

子宮内膜症治療市場の成長と動向

グランドビューリサーチ社の最新レポートによると、子宮内膜症治療の世界市場規模は2030年までに32億米ドルに達すると予測されています。同市場は2023年から2030年にかけてCAGR13.5%で拡大する見込みです。市場の成長は、後期の強力な製品パイプラインの存在、世界の症例の急増、政府および主要企業が国内および国際レベルで行っている疾患啓発のためのいくつかのイニシアチブに起因しています。

宇宙における新たな治療オプションの研究開発の高まりは、今後数年間、市場成長のための有利な機会を提供すると期待されています。Myovant/Pfizer社のRelugolix配合錠、ObsEva社のYselty（linzagolix）、Ferring Pharmaceuticals/Novartis社のQuinagolideは、この分野における著名な医薬品として、市場成長を促進することが予想されます。

子宮内膜症治療に対する需要の高まりは、疾病負担の増加や診断の遅れによる病状の悪化に起因しています。2021年3月、WHOの発表によると、世界では女性の生殖器人口の約10％がこの病気の影響を受けているとされています。論文「Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs」によると、最初の症状を発症してから3年以上診断が遅れると、症状発症後早期に診断された患者さんと比較して、症状負担の増加、医療費の50%増につながるとしています。

WHOや各国政府、民間団体は、子宮内膜症やその治療法に関する普及啓発に戦略的に取り組んでおり、市場の成長を支えています。例えば、2022年3月、Endometriosis Foundation of Americaは、患者と医師が出演するバーチャルプログラムを4週末開催し、子宮内膜症の戦士たちをつなぎ、この病気に関する経験を共有するのに貢献しました。さらに、2022年3月には、英国子宮内膜症協会も「子宮内膜症アクション月間」中に8項目のアクションプランを開始しました。

さらに、主要企業は、M&A、提携、金融投資、地理的拡大などの戦略的な取り組みを行っており、子宮内膜症治療市場を促進しています。例えば、2021年11月、Organon and Co.はForendo Pharmaを買収すると発表し、Forendoの第2相臨床候補であるOR-6219などの子宮内膜症における新規薬剤の開発を支援することになります。

子宮内膜症治療薬市場レポートハイライト

治療タイプ別では、医師による処方率が高いことから、2022年にはホルモン療法分野が最大のシェアを占める

GnRHアゴニストおよびGnRHアンタゴニストの高い有効性と市場での入手性の向上により、2022年にはゴナドトロピン放出ホルモン（GnRH）セグメントが薬効別セグメントを支配した

2022年、投与経路別では経口剤が48.46%のシェアを占め、市場を独占。経口剤は、同領域の大半の製品において最も一般的かつ利便性の高い投与経路です。

2022年、流通チャネル別では、小売薬局が市場を独占。さらに、病院薬局は緩やかな成長を示すと予想されます。

2021年の世界市場は、疾病の発生率の増加、疾病治療に関する人々や医療従事者の高い認識により、北米が支配的でした。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース：
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ：商品フローアプローチ
• 調査の仮定
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場のスナップショット
• セグメントのスナップショット
• 競合のスナップショット

第3章 子宮内膜症治療：市場変数、動向、および範囲

• 市場系列の見通し
• 浸透と成長の見通しのマッピング
• 規制状況
• 市場力学
• 市場促進要因分析
  • 疾病負担の増加
  • 病気に対する意識の高まり
  • 研究開発資金の増加
• 市場抑制要因分析
  • 一般用医薬品とジェネリック医薬品の入手可能性
• PESTEL分析
• 業界分析- ポーターの5つの力
• パイプライン分析

第4章 子宮内膜症治療市場：セグメント分析、治療タイプ別、2018年から2030年（百万米ドル）

• 子宮内膜症治療市場：治療タイプの変動分析
• 鎮痛薬
• ホルモン療法

第5章 子宮内膜症治療市場：セグメント分析、薬剤クラス別、2018年～2030年（100万米ドル）

• 子宮内膜症治療：薬物クラスの変動分析
• NSAID
• 経口避妊薬
• ゴナドトロピン放出ホルモン
• その他

第6章 子宮内膜症治療市場：セグメント分析、投与経路別、2018年から2030年（百万米ドル）

• 子宮内膜症治療市場：投与経路、変動分析
• オーラル
• 注射可能
• その他

第7章 子宮内膜症治療市場：セグメント分析、流通チャネル別、2018年から2030年（百万米ドル）

• 子宮内膜症治療市場：流通チャネル、変動分析
• 病院薬局
• 小売薬局
• その他

第8章 子宮内膜症治療市場：セグメント分析、地域別、2018年から2030年（百万米ドル）

• 地域市場のスナップショット
• 地域市場シェア分析、2021年および2030年
• 市場規模、予測、および収益とトレンドの分析、2021年から2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
    • APACのその他諸国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • 残りのラテンアメリカ
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート
    • MEAの解像度

第9章 子宮内膜症治療市場：競合分析

• 戦略イニシアチブと影響分析：主要市場参入企業別
  • 相乗効果分析：主要取引と戦略的提携
    • 新製品の発売
    • 合併と買収
    • ライセンシング契約
• 会社の分類
  • イノベーター
  • 市場のリーダー
  • 新興プレーヤー
  • ヒートマップ分析
• 会社の市況分析
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 潜在的なエンドユーザーのリスト
  • 主要企業の市場シェア分析、2021年
  • Consumer Behavior Analysis
  • Competitive Dashboard Analysis
• 非公開会社
  • 主要新興企業一覧
  • 地域ネットワークマップ
• 企業プロファイル
  • Bayer AG
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Pfizer, Inc
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • AbbVie, Inc
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • AstraZeneca
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • ObsEva SA
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Teva Pharmaceutical Industries
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Zydus Healthcare Limited
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Eli Lilly and Company
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Astellas Pharma Inc
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 List of Parameters
• Table 4 List of Distributors
• Table 5 Global Endometriosis Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 9 Global Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 10 North America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 12 North America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 23 Europe Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 24 Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 25 Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 26 Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 27 Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 28 Germany Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 29 Germany Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 30 Germany Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 31 Germany Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 32 U.K. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 33 U.K. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 34 U.K. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 35 U.K. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 36 France Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 37 France Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 38 France Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 39 France Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 40 Italy Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 41 Italy Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 42 Italy Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 43 Italy Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 44 Spain Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 45 Spain Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 46 Spain Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 47 Spain Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 48 Denmark Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 49 Denmark Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 50 Denmark Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 51 Denmark Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 52 Sweden Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 53 Sweden Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 54 Sweden Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 55 Sweden Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 56 Norway Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 57 Norway Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 58 Norway Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 59 Norway Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 60 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 61 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 62 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 63 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 67 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 68 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 69 Japan Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 70 Japan Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 71 Japan Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 72 Japan Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 73 China Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 74 China Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 75 China Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 76 China Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 77 India Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 78 India Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 79 India Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 80 India Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 81 South Korea Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 82 South Korea Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 83 South Korea Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 84 South Korea Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 85 Australia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 86 Australia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 87 Australia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 88 Australia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 89 Thailand Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 90 Thailand Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 91 Thailand Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 92 Thailand Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 93 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 94 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 95 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 96 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 97 Latin America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 98 Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 99 Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 100 Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 101 Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 102 Brazil Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 103 Brazil Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 104 Brazil Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 105 Brazil Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 106 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 107 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 108 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 109 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 110 Argentina Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 111 Argentina Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 112 Argentina Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 113 Argentina Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 114 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 115 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 116 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 117 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 118 Middle East & Africa Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 119 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 120 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 121 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 122 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 123 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 124 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 125 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 126 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 127 South Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 128 South Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 129 South Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 130 South Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 131 UAE Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 132 UAE Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 133 UAE Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 134 UAE Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 135 Kuwait Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 136 Kuwait Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 137 Kuwait Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 138 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 139 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
• Table 140 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 141 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 142 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Endometriosis Treatment Market Segmentation
• Fig. 2 Market Research Process
• Fig. 3 Information Procurement
• Fig. 4 Primary Research Pattern
• Fig. 5 Market Research Approaches
• Fig. 6 Value Chain-Based Sizing & Forecasting
• Fig. 7 QFD Modeling for Market Share Assessment
• Fig. 8 Market Formulation & Validation
• Fig. 9 Commodity Flow Approach
• Fig. 10 Market Snapshot (2022) (USD Million)
• Fig. 11 Segment Snapshot (2022) (USD Million)
• Fig. 12 Competitive Snapshot
• Fig. 13 Penetration & Growth Prospect Mapping
• Fig. 14 Endometriosis Treatment Market Driver Impact
• Fig. 15 Endometriosis Treatment Market Restraint Impact
• Fig. 16 PESTEL Analysis
• Fig. 17 Porter's Five Forces Analysis
• Fig. 18 Endometriosis Treatment, Treatment Type Outlook: Key Takeaways
• Fig. 19 Endometriosis Treatment Market: Treatment Type Movement Analysis (USD Million)
• Fig. 20 Pain Medication Market 2018 - 2030 (USD Million)
• Fig. 21 Hormone Therapy Market, 2018 - 2030 (USD Million)
• Fig. 22 Endometriosis Treatment Market: Drug Class Movement Analysis (USD Million)
• Fig. 23 NSAIDs Market, 2018 - 2030 (USD Million)
• Fig. 24 Oral Contraceptive, Market, 2018 - 2030 (USD Million)
• Fig. 25 Progestin Market, 2018 - 2030 (USD Million)
• Fig. 26 Gonadotropin Releasing Hormone Market, 2018 - 2030 (USD Million)
• Fig. 27 Danazol Market, 2018 - 2030 (USD Million)
• Fig. 28 Others Market, 2018 - 2030 (USD Million)
• Fig. 29 Endometriosis Treatment, Route of Administartion Outlook: Key Takeaways
• Fig. 30 Endometriosis Treatment Market: Route of Administartion Movement Analysis (USD Million)
• Fig. 31 Oral Market, 2018 - 2030 (USD Million)
• Fig. 32 Injectable Market, 2018 - 2030 (USD Million)
• Fig. 33 Others Market, 2018 - 2030 (USD Million)
• Fig. 34 Endometriosis Treatment Market Distribution Channel Outlook: Key Takeaways
• Fig. 35 Hospital pharmacy Market, 2018 - 2030 (USD Million)
• Fig. 36 Retail pharmacy Market, 2018 - 2030 (USD Million)
• Fig. 37 Others Market, 2018 - 2030 (USD Million)
• Fig. 38 Regional Snapshot, 2021 & 2030
• Fig. 39 Regional Market Place: Key takeaways
• Fig. 40 North America
• Fig. 41 North America Endometriosis Treatment Market, 2018 - 2030 (USD million)
• Fig. 42 U.S.
• Fig. 43 U.S. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 44 Canada
• Fig. 45 Canada Endometriosis Treatment Market, 2018 - 2030 (USD million)
• Fig. 46 Europe
• Fig. 47 Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 48 U.K.
• Fig. 49 U.K. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 50 Germany
• Fig. 51 Germany Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 52 Spain
• Fig. 53 Spain Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 54 France
• Fig. 55 France Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 56 Italy
• Fig. 57 Italy Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 56 Denmark
• Fig. 57 Denmark Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 56 Sweden
• Fig. 57 Sweden Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 56 Norway
• Fig. 57 Norway Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 56 Rest of Europe
• Fig. 57 Rest of Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific
• Fig. 59 Asia Pacific Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 60 Japan
• Fig. 61 Japan Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 62 China
• Fig. 63 China Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 64 India
• Fig. 65 India Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 66 Australia
• Fig. 67 Australia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 68 South Korea
• Fig. 69 South Korea Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 70 Thailand
• Fig. 71 Thailand Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 72 Rest of APAC
• Fig. 73 Rest of APAC Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 74 Latin America
• Fig. 75 Latin America Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 76 Brazil
• Fig. 77 Brazil Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 78 Mexico
• Fig. 79 Mexico Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 80 Argentina
• Fig. 81 Argentina Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 82 Rest of LATAM
• Fig. 83 Rest of LATAM Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 84 Middle East & Africa
• Fig. 85 MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 86 South Africa
• Fig. 87 South Africa Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 88 Saudi Arabia
• Fig. 89 Saudi Arabia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 90 UAE
• Fig. 91 UAE Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 92 Kuwait
• Fig. 93 Kuwait Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 94 Rest of MEA
• Fig. 95 Rest of MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
• Fig. 96 Heat Map Analysis
• Fig. 97 Company Market Position Analysis, 2021
• Fig. 98 Company Market Position Analysis, 2021
• Fig. 99 Company Market Share Analysis (2021)
• Fig. 100 Consumer Behavior Analysis
• Fig. 101 Market Differentiators

Endometriosis Treatment Market Growth & Trends:

The global endometriosis treatment market size is expected to reach USD 3.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is exected to expand at a CAGR of 13.5% from 2023 to 2030. The market growth is attributed to the presence of a late-stage robust product pipeline, the global upsurge in cases, and several initiatives undertaken by the government and key players at national and international levels to raise disease awareness.

The growing research and development for new treatment options in space is expected to offer a lucrative opportunity for market growth in the coming years. The launch of Myovant / Pfizer's Relugolix combination tablet, ObsEva's Yselty (linzagolix), and Ferring Pharmaceuticals / Novartis' Quinagolide are among prominent drug launches in this space that are anticipated to fuel the market growth.

Rising demand for endometriosis treatment is attributed to increasing disease burden and delay in diagnosis, worsening the disease condition. In March 2021, as per WHO, approximately 10% of female reproductive population is affected by the disease worldwide. According to the article, "Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs", a delay of three or more years in diagnosis from developing first symptom leads to increase in symptom burden and increase in healthcare cost by 50% compared with patients who were diagnosed earlier after symptom onset.

WHO, national governments, and private organizations are strategically involved in spreading awareness and educating people about endometriosis and its treatment, thereby supporting market growth. For instance, in March 2022, the Endometriosis Foundation of America hosted four weekends of the virtual program featuring patients and physicians, helping to connect endometriosis warriors and share their experiences with the disease. Moreover, in March 2022, Endometriosis U.K. also launched an eight-point action plan during the 'Endometriosis Action Month'.

Furthermore, key players are undertaking strategic initiatives such as mergers and acquisitions, collaborations, financial investments, and geographical expansion fueling the endometriosis treatment market. For instance, in November 2021, Organon and Co. announced to acquire Forendo Pharma, which will support Forendo's development of novel drugs in endometriosis like OR-6219, a phase 2 clinical candidate.

Endometriosis Treatment Market Report Highlights:

• By treatment type, the hormone therapy segment accounted for the largest share of the market in 2022 due to the high prescription rate of these drugs by physicians

• Gonadotropin-releasing hormone (GnRH) segment dominated the drug class segment in 2022 due to the high efficacy of GnRH agonists and GnRH antagonists and the increased availability of these products in the market

• In 2022, oral segment dominated the market with a 48.46% share by route of administration. It is the most common & convenient route of delivery for the majority of products in this space

• In 2022, retail pharmacy segment dominatedthe market by distribution channel. Moreover, hospital pharmacy is expected to demonstrate moderate growth

• North America dominated the global market in 2021 owing to increased disease incidence and high awareness among people and healthcare professionals about the condition therapies

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation and Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Snapshot

Chapter 3 Endometriosis Treatment: Market Variables, Trends, and Scope

• 3.1 Market Lineage Outlook
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Regulatory Landscape
• 3.4 Market Dynamics
• 3.5 Market Driver Analysis
  • 3.5.1 Rising disease burden
  • 3.5.2 Growing awareness for the disease
  • 3.5.3 Increasing funding for research and development
• 3.6 Market Restraint Analysis
  • 3.6.1.1 Availability of over the counter and generic drugs
• 3.7 PESTEL Analysis
• 3.8 Industry Analysis-Porter's Five Forces
• 3.9 Pipeline Analysis

Chapter 4 Endometriosis Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

• 4.1 Endometriosis Treatment Market: Treatment Type Movement Analysis
• 4.2 Pain Medication
  • 4.2.1 Pain Medication Market, 2018 - 2030 (USD Million)
• 4.3 Hormonal Therapy
  • 4.3.1 Hormonal Therapy Market, 2018 - 2030 (USD Million)

Chapter 5 Endometriosis Treatment Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

• 5.1 Endometriosis Treatment: Drug Class Movement Analysis
• 5.2 NSAIDs
  • 5.2.1 NSAIDs Market, 2018 - 2030 (USD Million)
• 5.3 Oral Contraceptive
  • 5.3.1 Oral Contraceptive Market, 2018 - 2030 (USD Million)
• 5.4 Gonadotropin Releasing Hormone
  • 5.4.1 Gonadotropin Releasing Hormone, Market, 2018 - 2030 (USD Million)
• 5.5 Others
  • 5.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Endometriosis Treatment Market: Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)

• 6.1 Endometriosis Treatment Market: Route of Administration, Movement Analysis
• 6.2 Oral
  • 6.2.1 Oral Market, 2018 - 2030 (USD Million)
• 6.3 Injectable
  • 6.3.1 Injectable Market, 2018 - 2030 (USD Million)
• 6.4 Others
  • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Endometriosis Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

• 7.1 Endometriosis Treatment Market: Distribution Channel, Movement Analysis
• 7.2 Hospital pharmacy
  • 7.2.1 Hospital pharmacy Market, 2018 - 2030 (USD Million)
• 7.3 Retail pharmacy
  • 7.3.1 Retail pharmacy Market, 2018 - 2030 (USD Million)
• 7.4 Others
  • 7.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Endometriosis Treatment Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 8.1 Regional Market Snapshot
• 8.2 Regional Market Share Analysis, 2021 & 2030
• 8.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2021 to 2030
  • 8.3.1 North America
    • 8.3.1.1 North America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.1.2 U.S.
    • 8.3.1.2.1 U.S. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.1.3 Canada
    • 8.3.1.3.1 Canada Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 8.3.2 Europe
    • 8.3.2.1 Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.2 U.K.
    • 8.3.2.2.1 U.K. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.3 Germany
    • 8.3.2.3.1 Germany Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.4 Spain
    • 8.3.2.4.1 Spain Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.5 France
    • 8.3.2.5.1 France Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.6 Italy
    • 8.3.2.6.1 Italy Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.7 Denmark
    • 8.3.2.7.1 Denmark Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.8 Sweden
    • 8.3.2.8.1 Sweden Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.9 Norway
    • 8.3.2.9.1 Norway Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2.10 Rest of Europe
    • 8.3.2.10.1 Rest of Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 8.3.3 Asia Pacific
    • 8.3.3.1 Asia Pacific Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3.2 Japan
    • 8.3.3.2.1 Japan Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3.3 China
    • 8.3.3.3.1 China Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3.4 India
    • 8.3.3.4.1 India Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3.5 Australia
    • 8.3.3.5.1 Australia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3.6 South Korea
    • 8.3.3.6.1 South Korea Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3.7 Thailand
    • 8.3.3.7.1 Thailand Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3.8 Rest of APAC
    • 8.3.3.8.1 Rest of APAC Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 8.3.4 Latin America
    • 8.3.4.1 Latin America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.4.2 Brazil
    • 8.3.4.2.1 Brazil Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.4.3 Mexico
    • 8.3.4.3.1 Mexico Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.4.4 Argentina
    • 8.3.4.4.1 Argentina Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.4.4 Rest of LATAM
    • 8.3.4.5.1 Rest of LATAM Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 8.3.5 MEA
    • 8.3.5.1 MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.5.2 South Africa
    • 8.3.5.2.1 South Africa Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.5.3 Saudi Arabia
    • 8.3.5.3.1 Saudi Arabia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.5.4 UAE
    • 8.3.5.4.1 UAE Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.5.4 Kuwait
    • 8.3.5.4.1 KuwaitEndometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.5.4 Reso of MEA
    • 8.3.5.4.1 Rest of MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 9 Endometriosis Treatment Market: Competitive Analysis

• 9.1 Strategic Initiatives and Impact Analysis, by Key Market Participants
  • 9.1.1 Synergy Analysis: Major Deals and Strategic Alliances
    • 9.1.1.1 New Product Launches
    • 9.1.1.2 Mergers and Acquisitions
    • 9.1.1.3 Licensing Agreements
• 9.2 Company Categorization
  • 9.2.1 Innovators
  • 9.2.2 Market Leaders
  • 9.2.3 Emerging Players
  • 9.2.4 Heat Map Analysis
• 9.3 Company Market Position Analysis
• 9.4 Vendor Landscape
  • 9.4.1 List of Key Distributors and Channel Partners
  • 9.4.2 List of Potential End-Users
  • 9.4.3 Key Company Market Share Analysis, 2021
  • 9.4.4 Consumer Behavior Analysis
  • 9.4.5 Competitive Dashboard Analysis
• 9.5 Private Companies
  • 9.5.1 List of Key Emerging Companies
  • 9.5.2 Regional Network Map
• 9.6 Company Profiles
  • 9.6.1 Bayer AG
    • 9.6.1.1 Company Overview
    • 9.6.1.2 Financial Performance
    • 9.6.1.3 Product Benchmarking
    • 9.6.1.4 Strategic Initiatives
  • 9.6.2 Pfizer, Inc
    • 9.6.2.1 Company Overview
    • 9.6.2.2 Financial Performance
    • 9.6.2.3 Product Benchmarking
    • 9.6.2.4 Strategic Initiatives
  • 9.6.3 AbbVie, Inc
    • 9.6.3.1 Company Overview
    • 9.6.3.2 Financial Performance
    • 9.6.3.3 Product Benchmarking
    • 9.6.3.4 Strategic Initiatives
  • 9.6.4 AstraZeneca
    • 9.6.4.1 Company Overview
    • 9.6.4.2 Financial Performance
    • 9.6.4.3 Product Benchmarking
    • 9.6.4.4 Strategic Initiatives
  • 9.6.5 ObsEva SA
    • 9.6.5.1 Company Overview
    • 9.6.5.2 Financial Performance
    • 9.6.5.3 Product Benchmarking
    • 9.6.5.4 Strategic Initiatives
  • 9.6.6 Teva Pharmaceutical Industries
    • 9.6.6.1 Company Overview
    • 9.6.6.2 Financial Performance
    • 9.6.6.3 Product Benchmarking
    • 9.6.6.4 Strategic Initiatives
  • 9.6.7 Zydus Healthcare Limited
    • 9.6.7.1 Company Overview
    • 9.6.7.2 Financial performance
    • 9.6.7.3 Product Benchmarking
    • 9.6.7.4 Strategic Initiatives
  • 9.6.8 Eli Lilly and Company
    • 9.6.8.1 Company Overview
    • 9.6.8.2 Financial performance
    • 9.6.8.3 Product Benchmarking
    • 9.6.8.4 Strategic Initiatives
  • 9.6.9 Astellas Pharma Inc
    • 9.6.9.1 Company Overview
    • 9.6.9.2 Financial performance
    • 9.6.9.3 Product Benchmarking
    • 9.6.9.4 Strategic Initiatives